Twist Bioscience reveals systematic sequencing gaps in cancer gene analysis as stock trades lower

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience drops 2.94% today

Highlights

TWST maintains a strong bullish trend across all major timeframes, supported by sustained trading above key moving averages.
Momentum indicators overwhelmingly signal ongoing strength but also indicate overbought conditions and short-term buyer exhaustion.
Price is expected to consolidate between $95.00 and $105.00 next week, with a breakout above $105.00 likely driving gains to new highs.

The company stated this is not because the mutations are absent. GC-rich regions are hard to sequence.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend sustained as price holds above layered support zones

TWST is trading above key moving averages, with the current price of $99.24 positioned well above the SMA-20 ($84.91), SMA-50 ($69.62), and SMA-200 ($46.34), confirming a robust bullish structure across short-, medium-, and long-term timeframes. The Ichimoku Kijun level on D1 at $84.21 sits below the current price, now serving as immediate support; near-term support is found at the Ichimoku Kijun and SMA-20 around $84.20–$84.90, while key support lies at SMA-50 near $69.62; near-term resistance is seen at the SMA-5 ($100.51), with key resistance at the SMA-10 ($94.83) and the 52-week high ($105.41).

Buyer momentum eases amid overbought signals and recent pullback

Momentum signals on D1 show strong underlying bullishness, as both MACD and ADX are firmly in buy territory, while RSI is elevated at 71.90, indicating overbought conditions. Stoch RSI and CCI also suggest an overbought to neutral stance, yet BBP points to short-term buyer exhaustion. The Awesome Oscillator remains neutral. TWST has declined $0.60 (0.60%) over the last week from a previous close of $99.84, now sitting in the lower part of the weekly range after a retreat from recent highs. Weekly volatility stands at a notable 10.55%. In today's session, the price has dropped 2.94% amid heavier selling, adding a corrective note to what has mostly been a steady advance.

Upside favored as strong buy signals outweigh near-term correction risk

For the coming week, the anticipated price range is $95.00 to $105.00, fitting within ±10% of the current price and respecting both typical volatility and the 52-week high ($105.41) and low ($23.30). The probability of further price increases is very high (more than 80%), given that all four major W1 trend indicators (RSI, ADX, MACD, MA-50) are in strong buy territory, making a decline less likely. Baseline scenario: price consolidates between $95.00 and $105.00. Bullish scenario: a move above $105.00 may trigger momentum toward new highs. Bearish scenario: a dip below $95.00 could prompt a short-term correction toward $90.00, but long-term structure remains positive.

Previously it was reported that Twist Bioscience was maintaining a strong bullish trend, with technical signals pointing to continued upward momentum. In light of more recent developments, investors should remain attentive to any emerging shifts in price action that could present either a breakout opportunity or signal an impending correction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.